Federal award
MAPP BIOPHARMACEUTICAL, INC.
HDTRA12010010
Assistance
Obligated and Ceiling
- Obligated (net)
- $1,465,844.55
- Potential value
- —
- Current value
- —
- Gross positive obligations
- $1,544,451.48
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- MAPP BIOPHARMACEUTICAL, INC. · M9V9QTHR1H28
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- —
- Awarding agency
- Department of Defense · sub-agency 9763 · office S0512A
- Funding agency
- Department of Defense · sub-agency 9761
- Assistance listing (CFDA)
- CFDA 12.351
- FAIN
- HDTRA12010010
- Award type code
- 04
- Actions
- 10 · Jun 12, 2020 to Sep 25, 2025
- Why it is listed
- a program on the reviewed research-assistance allowlist (DoD, DOE or NASA from $10k, or eligible DHS research)
Action History10
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Sep 25, 2025 | FY2025 | A00001 | FX | −$78,606.93 | — |
| May 30, 2024 | FY2024 | P00008 | B1 | $86,632.48 | — |
| Apr 18, 2024 | FY2024 | P00007 | B1 | $150,000.00 | — |
| Feb 29, 2024 | FY2024 | P00006 | B1 | $0.00 | — |
| May 18, 2023 | FY2023 | P00005 | B1 | $0.00 | — |
| May 25, 2022 | FY2022 | P00004 | B1 | $277,822.20 | — |
| Mar 17, 2022 | FY2022 | P00003 | B1 | $57,563.00 | — |
| Apr 28, 2021 | FY2021 | P00002 | B1 | $272,053.69 | — |
| Mar 1, 2021 | FY2021 | P00001 | B1 | $300,000.00 | — |
| Jun 12, 2020 | FY2020 | 0 | A1 | $400,380.11 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.